Science Explorer Back to mapMap
Discussion
Topic · Epidemiology

Trypanosoma species research and implications

Trypanosoma species research and implications is a research topic within Epidemiology. Science Explorer counts 30k research works in it since 1950. 10.0% of them reached the world's top 10% most cited for their field and year.

This cluster of papers covers a wide range of topics related to Chagas disease, including the epidemiology, genomics, treatment, and control strategies. It discusses the causative agent Trypanosoma cruzi, the impact of Chagas disease in Latin America and non-endemic countries, as well as the challenges of drug resistance and the development of new therapies. Additionally, it explores the clinical aspects such as cardiomyopathy and provides insights into the molecular mechanisms underlying the disease.

  • Trypanosoma cruzi
  • Chagas Disease
  • African Trypanosomiasis
  • Glycosylphosphatidylinositol
  • Chemotherapy
  • Epidemiology
  • Genome Sequence
  • Vector Control
  • Cardiomyopathy
  • Drug Resistance
Research works
30k
fractional, since 1950
In the world top 10%
3k
per year above
Top-10% rate
10.0%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
-11%
the tick is no change
Largest producer
Brazil
32% of the 10 largest, 2022-now
Trypanosoma species research and implications

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Trypanosoma species research and implications research?

By volume, Brazil and the United States publish the most (841 and 560 works in 2022-now).

By volume, 2022-now

  1. 1 Brazil 841 works
  2. 2 United States 560 works
  3. 3 India 238 works
  4. 4 United Kingdom 202 works
  5. 5 Spain 160 works
  6. 6 Argentina 151 works
  7. 7 China 134 works
  8. 8 Mexico 128 works
  9. 9 France 120 works
  10. 10 Germany 108 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

Brazil: 31.8%United States: 21.2%India: 9.0%United Kingdom: 7.6%6 others listed: 30.3%32%largest
Brazil841 · 31.8%United States560 · 21.2%India238 · 9.0%United Kingdom202 · 7.6%6 others listed801 · 30.3%

Shares of the rows listed above, not of the whole node.

Which institutions lead Trypanosoma species research and implications research?

By volume in 2022-now, Fundação Oswaldo Cruz publishes the most Trypanosoma species research and implications research, followed by Universidade de São Paulo and Universidade Federal de Minas Gerais.

Who are the leading researchers in Trypanosoma species research and implications?

The most-cited researchers publishing on Trypanosoma species research and implications include Simon Iain Hay, Steven L. Salzberg and John J.V. McMurray.

  1. 1 Simon Iain Hay United States 452k citations
  2. 2 Steven L. Salzberg United States 372k citations
  3. 3 John J.V. McMurray United Kingdom 349k citations
  4. 4 Shizuo Akira Japan 342k citations
  5. 5 Giuseppe Remuzzi Italy 328k citations
  6. 6 Elie A. Akl Canada 313k citations
  7. 7 Matthias Mann Germany 308k citations
  8. 8 Salim Yusuf Canada 294k citations
  9. 9 Yousef Saleh Khader Jordan 274k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Trypanosoma species research and implications?

The most cited paper in Trypanosoma species research and implications is "Prevalence of Lysosomal Storage Disorders" (Peter J. Meikle, 1999), with 2,215 citations. Next come "Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease" (2,179) and "Chagas disease" (2,143).

Most cited papers
#PaperReleasedCitations
1 Prevalence of Lysosomal Storage Disorders Peter J. Meikle · JAMA 20 Jan 1999 2,215
2 Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease E. Sidransky et al. · New England Journal of Medicine Open access 21 Oct 2009 2,179
3 Chagas disease Anis Rassi, Anis Rassi, Anis Rassi et al. · The Lancet Apr 2010 2,143
4 Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans Giulio Genovese, David J. Friedman, Michael David Ross et al. · Science Open access 15 Jul 2010 2,062
5 Advances in leishmaniasis Henry W. Murray, Jonathan D. Berman, Clive R. Davies et al. · The Lancet Oct 2005 1,786
All 100 most cited papers, with filters and sorting

Where is Trypanosoma species research and implications research done?

The largest centres of Trypanosoma species research and implications research in 2022-now are Rio de Janeiro (Brazil), São Paulo (Brazil), Buenos Aires (Argentina) and Belo Horizonte (Brazil). Among places with at least 20 works in it, it is an unusually large share of all research in Montevideo.

Largest cities, 2022-now

  1. 1 Rio de JaneiroBrazil 183 works
  2. 2 São PauloBrazil 163 works
  3. 3 Buenos AiresArgentina 90 works
  4. 4 Belo HorizonteBrazil 72 works
  5. 5 Mexico CityMexico 58 works
  6. 6 MadridSpain 55 works
  7. 7 LondonUnited Kingdom 53 works
  8. 8 ParisFrance 49 works
  9. 9 BogotáColombia 39 works
  10. 10 MontevideoUruguay 33 works

Where it is the local speciality

  1. MontevideoUY · 32.7 works21×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Trypanosoma species research and implications than the world average.

See Trypanosoma species research and implications on the map

Where is the best place to study Trypanosoma species research and implications?

Among universities, judged by research, Charles University, Universidade Federal de Minas Gerais and University of York score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%10%20%mean 15.48%fractional works in this field (log) →share of work in the world top 10% →Banaras Hindu Univer…Charles UniversityUniversity of YorkUniversidade Federal…
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Charles UniversityCzechia 61.220.5%7.6×12 +8.4%
2Universidade Federal de Minas GeraisBrazil 59.610.8%20.8×53 -6.8%
3University of YorkUnited Kingdom 59.118.1%8.9×10 +5.7%
4Banaras Hindu UniversityIndia 57.522.7%4.1×11 +9.2%
5Universidade de São PauloBrazil 56.37.1%9.1×64 -23.5%
6University of OxfordUnited Kingdom 55.119.6%2.8×14 -24.6%
7University of DundeeUnited Kingdom 54.418.3%24.1×15 -17.6%
8University of GlasgowUnited Kingdom 53.017.5%6.5×15 -36.1%
9Universidad de la República de UruguayUruguay 52.68.9%20.0×18 +47.9%
10London School of Hygiene & Tropical MedicineUnited Kingdom 52.411.3%24.2×13 -16.7%

Universities only. The score blends excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Trypanosoma species research and implications, country by country

Is Trypanosoma species research and implications research growing?

Output in 2022-2025 was 11% lower than in 2018-2021, peaking in 2021.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Trypanosoma species research and implications as a percentage of every work published that year, 0.016% in 2024.

still counting0.020%0.040%0.060%Trypanosoma species research and implications0.016% in 202519801990200020102020

Fractional works of Trypanosoma species research and implications over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Trypanosoma species research and implications10.4% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Trypanosoma species research and implications. Posts are plain text and can be reported.